Literature DB >> 27390093

Mitochondria-Targeting Magnetic Composite Nanoparticles for Enhanced Phototherapy of Cancer.

Ranran Guo1, Haibao Peng1, Ye Tian1, Shun Shen2, Wuli Yang1.   

Abstract

Photothermal therapy (PTT) and photodynamic therapy (PDT) are promising cancer treatment modalities in current days while the high laser power density demand and low tumor accumulation are key obstacles that have greatly restricted their development. Here, magnetic composite nanoparticles for dual-modal PTT and PDT which have realized enhanced cancer therapeutic effect by mitochondria-targeting are reported. Integrating PTT agent and photosensitizer together, the composite nanoparticles are able to generate heat and reactive oxygen species (ROS) simultaneously upon near infrared (NIR) laser irradiation. After surface modification of targeting ligands, the composite nanoparticles can be selectively delivered to the mitochondria, which amplify the cancer cell apoptosis induced by hyperthermia and the cytotoxic ROS. In this way, better photo therapeutic effects and much higher cytotoxicity are achieved by utilizing the composite nanoparticles than that treated with the same nanoparticles missing mitochondrial targeting unit at a low laser power density. Guided by NIR fluorescence imaging and magnetic resonance imaging, then these results are confirmed in a humanized orthotropic lung cancer model. The composite nanoparticles demonstrate high tumor accumulation and excellent tumor regression with minimal side effect upon NIR laser exposure. Therefore, the mitochondria-targeting composite nanoparticles are expected to be an effective phototherapeutic platform in oncotherapy.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  magnetic composite nanoparticles; mitochondria-targeting; multimode imaging; photodynamic therapy; photothermal therapy

Mesh:

Substances:

Year:  2016        PMID: 27390093     DOI: 10.1002/smll.201601094

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  15 in total

1.  Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment.

Authors:  Meijia Wu; Shengwu Huang
Journal:  Mol Clin Oncol       Date:  2017-08-28

2.  Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.

Authors:  Tao Wang; Jiahui Hou; Chang Su; Liang Zhao; Yijie Shi
Journal:  J Nanobiotechnology       Date:  2017-01-10       Impact factor: 10.435

3.  Mitochondria-Targeted Artificial "Nano-RBCs" for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation.

Authors:  Liang Zhang; Dong Wang; Ke Yang; Danli Sheng; Bin Tan; Zhigang Wang; Haitao Ran; Hengjing Yi; Yixin Zhong; Han Lin; Yu Chen
Journal:  Adv Sci (Weinh)       Date:  2018-05-21       Impact factor: 16.806

Review 4.  Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents.

Authors:  Suk Ho Hong; Yongdoo Choi
Journal:  J Pharm Investig       Date:  2017-09-09

5.  Targeting the Opening of Mitochondrial Permeability Transition Pores Potentiates Nanoparticle Drug Delivery and Mitigates Cancer Metastasis.

Authors:  Xi Lin; Lian Li; Shujie Li; Qiuyi Li; Dandan Xie; Minglu Zhou; Yuan Huang
Journal:  Adv Sci (Weinh)       Date:  2020-12-31       Impact factor: 16.806

6.  Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma.

Authors:  Wei-Nan Zeng; Qiu-Ping Yu; Duan Wang; Jun-Li Liu; Qing-Jun Yang; Zong-Ke Zhou; Yi-Ping Zeng
Journal:  J Nanobiotechnology       Date:  2021-03-19       Impact factor: 10.435

Review 7.  Targeted Nanomaterials for Phototherapy.

Authors:  Upendra Chitgupi; Yiru Qin; Jonathan F Lovell
Journal:  Nanotheranostics       Date:  2017-01-01

8.  Cancer-mitochondria-targeted photodynamic therapy with supramolecular assembly of HA and a water soluble NIR cyanine dye.

Authors:  Ajesh P Thomas; L Palanikumar; M T Jeena; Kibeom Kim; Ja-Hyoung Ryu
Journal:  Chem Sci       Date:  2017-10-13       Impact factor: 9.825

Review 9.  Mitochondria-targeting theranostics.

Authors:  Han Chang Kang
Journal:  Biomater Res       Date:  2018-11-08

10.  Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy.

Authors:  Hui Yu; Jia-Mi Li; Kai Deng; Wei Zhou; Cai-Xia Wang; Qian Wang; Kun-Heng Li; Hong-Yang Zhao; Shi-Wen Huang
Journal:  Theranostics       Date:  2019-09-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.